| 1 |
Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomicsequencing[J]. Nature, 2010,464(7285):59-65.
|
| 2 |
Chassard C, Lacroix C. Carbohydrates and the human gut microbiota[J]. Curr Opin Clin Nutr Metab Care, 2013,16(4):453-460.
|
| 3 |
Bengmark S. Gut microbial ecology in critical illness: is there a role for prebiotics, probiotics, and synbiotics[J]? Curr Opin Crit Care, 2002,8(2):145-151.
|
| 4 |
Kabat AM, Srinivasan N, Maloy KJ. Modulation of immune development and function by intestinal microbiota[J]. Trends Immunol, 2014,35(11):507-517.
|
| 5 |
Gensollen T, Iyer SS, Kasper DL, et al. How colonization by microbiota in early life shapes the immune system[J]. Science, 2016,352(6285):539-544.
|
| 6 |
Flint HJ, Duncan SH, Scott KP, et al. Interactions and competition within the microbial community of the human colon: links between diet and health[J]. Environ Microbiol, 2007,9(5):1101-1111.
|
| 7 |
Liu DQ, Gao QY, Liu HB, et al. Probiotics improve survival of septic rats by suppressing conditioned pathogens in ascites[J]. World J Gastroenterol, 2013,19(25):4053-4059.
|
| 8 |
Vartoukian SR, Palmer RM, Wade WG. Strategies for culture of ′unculturable′ bacteria[J]. FEMS Microbiol Lett, 2010,309(1):1-7.
|
| 9 |
Claesson MJ, Wang Q, O′Sullivan O, et al. Comparison of two next-generation sequencing technologies for resolving highly complex microbiota composition using tandem variable 16S rRNA gene regions[J]. Nucleic Acids Res, 2010,38(22):e200.
|
| 10 |
Hiergeist A, Reischl U, Gessner A. Multicenter quality assessment of 16S ribosomal DNA-sequencing for microbiome analyses reveals high inter-center variability[J]. Int J Med Microbiol, 2016,306(5):334-342.
|
| 11 |
Turnbaugh PJ, Quince C, Faith JJ, et al. Organismal, genetic, and transcriptional variation in the deeply sequenced gut microbiomes of identical twins[J]. Proc Nati Acad Sci U S A, 2010,107(16):7503-7508.
|
| 12 |
Greenblum S, Turnbaugh PJ, Borenstein E. Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease[J]. Proc Nati Acad Sci U S A, 2012,109(2):594-599.
|
| 13 |
Schloissnig S, Arumugam M, Sunagawa S, et al. Genomic variation landscape of the human gut microbiome[J]. Nature, 2013,493(7430):45-50.
|
| 14 |
Tolonen AC, Xavier RJ. Dissecting the human microbiome with single-cell genomics[J]. Genome Med, 2017,9(1):56.
|
| 15 |
Rinke C, Schwientek P, Sczyrba A, et al. Insights into the phylogeny and coding potential of microbial dark matter[J]. Nature, 2013,499(7459):431-437.
|
| 16 |
Woyke T, Xie G, Copeland A, et al. Assembling the marine metagenome, one cell at a time[J]. PloS One, 2009,4(4):e5299.
|
| 17 |
Marcy Y, Ouverney C, Bik EM, et al. Dissecting biological ″dark matter″ with single-cell genetic analysis of rare and uncultivated TM7 microbes from the human mouth[J]. Proc Nati Acad Sci U S A, 2007,104(29):11889-11894.
|
| 18 |
Lagier JC, Armougom F, Million M, et al. Microbial culturomics: paradigm shift in the human gut microbiome study[J]. Clin Microbiol Infect, 2012,18(12):1185-1193.
|
| 19 |
Lagier JC, Khelaifia S, Alou MT, et al. Culture of previously uncultured members of the human gut microbiota by culturomics[J]. Nat Microbiol, 2016,1:16203.
|
| 20 |
Lagkouvardos I, Overmann J, Clavel T. Cultured microbes represent a substantial fraction of the human and mouse gut microbiota[J]. Gut Microbes, 2017,8(5):493-503.
|
| 21 |
Kaur J. A comprehensive review on metabolic syndrome[J]. Cardiol Res Pract, 2014,2014:943162.
|
| 22 |
Bäckhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage[J]. Proc Nati Acad Sci U S A, 2004,101(44):15718-15723.
|
| 23 |
Turnbaugh PJ, Ley RE, Mahowald MA, et al. An obesity-associated gut microbiome with increased capacity for energy harvest[J]. Nature, 2006,444(7122):1027-1031.
|
| 24 |
Di Luccia B, Crescenzo R, Mazzoli A, et al. Rescue of fructose-induced metabolic syndrome by antibiotics or faecaltransplantation in a rat model of obesity[J]. PloS One, 2015,10(8):e0134893.
|
| 25 |
Guo X, Xia X, Tang R, et al. Development of a real-time PCR method for Firmicutes and Bacteroidetes in faeces and its application to quantify intestinal population of obese and lean pigs[J]. Lett Appl Microbiol, 2008,47(5):367-373.
|
| 26 |
Jumpertz R, Le DS, Turnbaugh PJ, et al. Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans[J]. Am J Clin Nutr, 2011,94(1):58-65.
|
| 27 |
Schwiertz A, Taras D, Schäfer K, et al. Microbiota and SCFA in lean and overweight healthy subjects[J]. Obesity (Silver Spring), 2010,18(1):190-195.
|
| 28 |
Santacruz A, Collado MC, García-Valdés L, et al. Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women[J]. Br J Nutr, 2010,104(1):83-92.
|
| 29 |
Pedersen HK, Gudmundsdottir V, Nielsen HB, et al. Human gut microbes impact host serum metabolome and insulin sensitivity[J]. Nature, 2016,535(7612):376-381.
|
| 30 |
Li J, Lin S, Vanhoutte PM, et al. AkkermansiaMuciniphila Protects Against Atherosclerosis by Preventing Metabolic Endotoxemia-Induced Inflammation in Apoe-/- Mice[J]. Circulation, 2016,133(24):2434-2446.
|
| 31 |
Kang JH, Yun SI, Park MH, et al. Anti-obesity effect of Lactobacillus gasseri BNR17 in high-sucrose diet-induced obese mice[J]. PloS One, 2013,8(1):e54617.
|
| 32 |
Zhou AL, Hergert N, Rompato G, et al. Whole grain oats improve insulin sensitivity and plasma cholesterol profile and modify gut microbiota composition in C57BL/6J mice[J]. J Nutr, 2015,145(2):222-230.
|
| 33 |
Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults[J]. Aliment Pharmacol Ther, 2011,34(3):274-285.
|
| 34 |
Compare D, Coccoli P, Rocco A, et al. Gut--liver axis: the impact of gut microbiota on non alcoholic fatty liver disease[J]. Nutr Metab Cardiovasc Dis, 2012,22(6):471-476.
|
| 35 |
Le RT, Llopis M, Lepage P, et al. Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice[J]. Gut, 2013,62(12):1787-1794.
|
| 36 |
Zhu L, Baker SS, Gill C, et al. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH[J]. Hepatology, 2013,57(2):601-609.
|
| 37 |
Grat M, Wronka KM, Krasnodebski M, et al. Profile of gut microbiota associated with the presence of hepatocellular cancer in patients with liver cirrhosis[J]. Transplantat Proc, 2016,48(5):1687-1691.
|